Mizuho Markets Americas LLC Halozyme Therapeutics, Inc. Transaction History
Mizuho Markets Americas LLC
- $7.24 Billion
- Q4 2024
A detailed history of Mizuho Markets Americas LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Mizuho Markets Americas LLC holds 467,283 shares of HALO stock, worth $27.2 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
467,283
Previous 375,446
24.46%
Holding current value
$27.2 Million
Previous $21.5 Million
4.01%
% of portfolio
0.31%
Previous 0.37%
Shares
10 transactions
Others Institutions Holding HALO
# of Institutions
545Shares Held
121MCall Options Held
419KPut Options Held
172K-
Black Rock Inc. New York, NY17.6MShares$1.02 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$772 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$385 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$236 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.07MShares$178 Million0.05% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.09B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...